First published · Last updated
The Impact of Tumor Immune Microenvironment in EGFR-Mutant Non-Small Cell Lung Cancer on the Efficacy of Osimertinib
Journal article studies the impact of the tumor immune microenvironment on the efficacy of osimertinib in EGFR-mutant non-small cell lung cancer. No further methodological, result, location, or participant details are included in the supplied source data.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
The article examines the relationship between tumor immune microenvironment and osimertinib efficacy in EGFR-mutant non-small cell lung cancer.

